DOES REVISED INTERNATIONAL PROGNOSITIC SCORING SYSTEM (IPSS-R) HAVE ANY IMPACT ON CLINICAL OUTCOMES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS?

被引：0
|
作者：
Teo, Z. [1 ]
Yiu, R. [1 ]
Yueh, L. Ling [1 ]
Ho, A. [1 ]
机构：
[1] Singapore Gen Hosp, Singhlth, Haematol, Singapore, Singapore
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P747
引用
收藏
页码：312 / 313
页数：2
相关论文
共 50 条
  • [31] Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms
    Polprasert, Chantana
    Niparuck, Pimjai
    Rattanathammethee, Thanawat
    Kobbuaklee, Sirorat
    Lanamtieng, Theerin
    Rojnuckarin, Ponlapat
    HEMATOLOGY, 2022, 27 (01) : 1294 - 1297
  • [32] The impact of clonal size on the revised international prognostic scoring system (R-IPSS) in myelodysplastic syndromes (MDS) with a single cytogenetic abnormality.
    Alkharabsheh, Omar
    Saadeh, Salwa Shihadeh
    Patnaik, Mrinal Mahesh
    Alkhateeb, Hassan
    Gangat, Naseema
    Begna, Kebede
    Hogan, William J.
    Greipp, Patricia T.
    He, Rong
    Nguyen, Phuong L.
    Litzow, Mark Robert
    Al-Kali, Aref
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] The Revised International Prognostic Scoring System (IPSS-R) Predicts Posttransplantation Outcome Of Patients With Myelodysplastic Syndrome Receiving Allogeneic Stem Cell Transplantation: A Basis For Clinical Decision Making
    Della Porta, Matteo G.
    Alessandrino, Emilio Paolo
    Bacigalupo, Andrea
    Allione, Bernardino
    Malcovati, Luca
    van Lint, Maria Teresa
    Bernardi, Massimo
    Onida, Francesco
    Bosi, Alberto
    Iori, Anna Paola
    Cerretti, Raffaella
    Marenco, Paola
    Pioltelli, Pietro
    Angelucci, Emanuele
    Oneto, Rosi
    Pascutto, Cristiana
    Cazzola, Mario
    Rambaldi, Alessandro
    BLOOD, 2013, 122 (21)
  • [34] Evaluation of IPSS-Revised (IPSS-R) Cytogenetic Risk Stratification and Prognostic Impact of Monosomal Karyotype in 1,014 Patients with Myelodysplastic Syndromes (MDS)
    Gangat, Naseema
    Patnaik, Mrinal M.
    Begna, Kebede
    Kourelius, Taxiarchis
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Hodnefield, Janice M.
    Hanson, Curtis A.
    Pardanani, Animesh
    Tefferi, Ayalew
    BLOOD, 2012, 120 (21)
  • [35] Prognostic Value of Circulating Myeloblasts in Patients with Myelodysplastic Syndromes (MDS): A Proposal for Incorporation in the Revised International Prognostic Scoring System (R-IPSS)
    Komrokji, Rami S.
    Padron, Eric
    Al Ali, Najla H.
    Lancet, Jeffrey E.
    Hall, Jeff
    Kwok, Brian
    Zhang, Ling
    Epling-Burnette, Pearlie K.
    List, Alan F.
    BLOOD, 2014, 124 (21)
  • [36] Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
    A Nazha
    M Narkhede
    T Radivoyevitch
    D J Seastone
    B J Patel
    A T Gerds
    S Mukherjee
    M Kalaycio
    A Advani
    B Przychodzen
    H E Carraway
    J P Maciejewski
    M A Sekeres
    Leukemia, 2016, 30 : 2214 - 2220
  • [37] Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
    Nazha, A.
    Narkhede, M.
    Radivoyevitch, T.
    Seastone, D. J.
    Patel, B. J.
    Gerds, A. T.
    Mukherjee, S.
    Kalaycio, M.
    Advani, A.
    Przychodzen, B.
    Carraway, H. E.
    Maciejewski, J. P.
    Sekeres, M. A.
    LEUKEMIA, 2016, 30 (11) : 2214 - 2220
  • [38] REPORT ON OUTCOME OF HYPOMETHYLATING THERAPY WITH ANALYSIS ON PROGNOSTIC VALUE OF REVISED-INTERNATIONAL PROGNOSTIC SCORING SYSTEM IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES OF LOWER-RISK BASED ON IPSS
    Lee, Y.
    Moon, J.
    Yoon, J.
    Kim, J.
    Sohn, S.
    HAEMATOLOGICA, 2016, 101 : 507 - 507
  • [39] Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)
    Della Porta, M. G.
    Tuechler, H.
    Malcovati, L.
    Schanz, J.
    Sanz, G.
    Garcia-Manero, G.
    Sole, F.
    Bennett, J. M.
    Bowen, D.
    Fenaux, P.
    Dreyfus, F.
    Kantarjian, H.
    Kuendgen, A.
    Levis, A.
    Cermak, J.
    Fonatsch, C.
    Le Beau, M. M.
    Slovak, M. L.
    Krieger, O.
    Luebbert, M.
    Maciejewski, J.
    Magalhaes, S. M. M.
    Miyazaki, Y.
    Pfeilstoecker, M.
    Sekeres, M. A.
    Sperr, W. R.
    Stauder, R.
    Tauro, S.
    Valent, P.
    Vallespi, T.
    van de Loosdrecht, A. A.
    Germing, U.
    Haase, D.
    Greenberg, P. L.
    Cazzola, M.
    LEUKEMIA, 2015, 29 (07) : 1502 - 1513
  • [40] Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes
    Lee, Yoo Jin
    Park, Sung Woo
    Lee, In Hee
    Ahn, Jae Sook
    Kim, Hyeoung Joon
    Chung, Joo Seop
    Shin, Ho Jin
    Lee, Won Sik
    Lee, Sang Min
    Joo, Young Don
    Kim, Hawk
    Lee, Ho Sup
    Kim, Yang Soo
    Cho, Yoon Young
    Moon, Joon Ho
    Sohn, Sang Kyun
    ANNALS OF HEMATOLOGY, 2016, 95 (11) : 1795 - 1804
12345